Expression of Mucin1 in saliva in oral squamous cell carcinoma and oral potentially malignant disorders (case control study)

被引:6
作者
Abdelwhab, Amira [1 ]
Shaker, Olfat [2 ]
Aggour, Reham Lotfy [1 ]
机构
[1] October 6 Univ, Fac Dent, Oral Med & Periodontol, Giza Governorate, Egypt
[2] Cairo Univ, Fac Med, Med Biochem & Mol Biol, Giza Governorate, Egypt
关键词
MUC1; Mucin1; oral squamous cell carcinoma; premalignant lesions; MUC1; MUCIN; PROGNOSTIC BIOMARKERS; CANCER; ANTIGENS; HEAD; MARKER; PROGRESSION; METASTASIS; INVASION; LESIONS;
D O I
10.1111/odi.14138
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Objectives Overexpression of mucin1 is found in head and neck squamous cell carcinoma tissues compared with adjacent non-neoplastic tissues and higher levels are associated with metastasis and invasion. The expression level of mucin1 in saliva of normal individuals, oral potentially malignant disorders and oral squamous cell carcinoma patients and its correlation to clinical and histological variables was evaluated. Subjects and Methods Forty oral potentially malignant disorders, 40 oral squamous cell carcinoma subjects, and 20 age matched-controls were included. Stimulated salivary samples were collected from all participants, and mucin1 expression was measured by real-time PCR. Results Mucin1 expression in saliva was significantly elevated in oral potentially malignant disorders when compared with controls. Similarly, mucin1 expression was significantly elevated in oral squamous cell carcinoma group when compared with oral potentially malignant disorders and controls. Mucin1 expression in OSCC patient showed significant positive correlations with T classification and distant Metastasis. Mucin1 expression in oral potentially malignant disorders patients showed significant positive correlations with degree of dysplasia. Conclusions The expression level of mucin1 in saliva might be a potential biomarker for diagnosing oral potentially malignant disorders and oral squamous cell carcinoma.
引用
收藏
页码:1487 / 1494
页数:8
相关论文
共 58 条
[1]   Oral field cancerization: Current evidence and future perspectives [J].
Punnya V. Angadi ;
J. K. Savitha ;
Sanjay S. Rao ;
Y. Sivaranjini .
Oral and Maxillofacial Surgery, 2012, 16 (2) :171-180
[2]   Blueprint of quartz crystal microbalance biosensor for early detection of breast cancer through salivary autoantibodies against ATP6AP1 [J].
Arif, Sania ;
Qudsia, Syeda ;
Urooj, Samina ;
Chaudry, Nazia ;
Arshad, Aneeqa ;
Andleeb, Saadia .
BIOSENSORS & BIOELECTRONICS, 2015, 65 :62-70
[3]   Preventing cancer by targeting abnormally expressed self-antigens: MUC1 vaccines for prevention of epithelial adenocarcinomas [J].
Beatty, Pamela L. ;
Finn, Olivera J. .
RENAISSANCE OF CANCER IMMUNOTHERAPY, 2013, 1284 :52-56
[4]   Levels of MUC1 in tumours and serum of patients with different sub-types of squamous cell carcinoma of the head and neck [J].
Boldrup, Linda ;
Coates, Philip ;
Gu, Xiaolian ;
Wang, Lixiao ;
Fahraeus, Robin ;
Wilms, Torben ;
Sgaramella, Nicola ;
Baumgarth, Jonathan ;
Norberg-Spaak, Lena ;
Nylander, Karin .
ONCOLOGY LETTERS, 2020, 20 (02) :1709-1718
[5]  
Broders A., 1941, Surg Clin North Amer, V21, P947
[6]   Soluble MUC1 and serum MUC1-specific antibodies are potential prognostic biomarkers for platinum-resistant ovarian cancer [J].
Budiu, Raluca A. ;
Mantia-Smaldone, Gina ;
Elishaev, Esther ;
Chu, Tianjiao ;
Thaller, Julia ;
McCabe, Kathryn ;
Lenzner, Diana ;
Edwards, Robert P. ;
Vlad, Anda M. .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2011, 60 (07) :975-984
[7]   The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research [J].
Cheever, Martin A. ;
Allison, James P. ;
Ferris, Andrea S. ;
Finn, Olivera J. ;
Hastings, Benjamin M. ;
Hecht, Toby T. ;
Mellman, Ira ;
Prindiville, Sheila A. ;
Viner, Jaye L. ;
Weiner, Louis M. ;
Matrisian, Lynn M. .
CLINICAL CANCER RESEARCH, 2009, 15 (17) :5323-5337
[8]   Challenges of the Oral Cancer Burden in India [J].
Coelho, Ken Russell .
JOURNAL OF CANCER EPIDEMIOLOGY, 2012, 2012
[9]   Differential expression of MUC1 and carbohydrate antigens in primary and secondary head and neck squamous cell carcinoma [J].
Croce, Maria V. ;
Rabassa, Martin E. ;
Pereyra, Adrian ;
Segal-Eiras, Amada .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2008, 30 (05) :647-657
[10]  
El-Naggar A. K., 2017, WHO classification of head and neck tumours: 9. WHO classification of head and neck tumours, V4th